An Australian researcher hopes to turn over a new leaf in treatment for people in hospital with a serious case of COVID-19.
CQUniversity’s Professor of Infectious Disease Immunology Andrew Tayor-Robinson believes he can use a common plant compound to help the worst-off patients.
When chlorophyll – the chemical that makes plants green – breaks down, it creates a zinc compound that produces electrically charged particles.
Professor Taylor-Robinson has published a paper in Frontiers in Plant Science, proposing that these particles could be used for treating viruses, including COVID-19.
He says that, while this type of treatment has not yet been explored, evidence from other medical disciplines suggests it has the potential to stop viruses from reproducing.
“It is increasingly clear that the COVID-19 global pandemic is not leaving us any time soon, so effective treatment of severe, hospitalised cases of infection is urgently required,” Professor Taylor-Robinson said.
He said laboratory tests would pave the way for future clinical therapy to be delivered deep inside human lungs.
“While our investigations are very much at a preliminary experimental stage, we’re suggesting that further research into this potential COVID-19 therapy be pursued,” he said.
Help make the grass greener for our universities as they search for ways to beat the pandemic – sign the petition to #KeepItClever now.